A 48-week real-world effectiveness of nemolizumab for pediatric patients with atopic dermatitis. Hagino T, Takahashi Y, Saeki H, Fujimoto E, et al. J Am Acad Dermatol 2026 Aug 5:S0190-9622(26)03229.

Read + Share

Amedeo Smart

Independent Medical Education

Hagino T, Takahashi Y, Saeki H, Fujimoto E, et al. A 48-week real-world effectiveness of nemolizumab for pediatric patients with atopic dermatitis. J Am Acad Dermatol 2026 Aug 5:S0190-9622(26)03229.
PMID: 42556738